These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37939201)

  • 1. A data-driven semi-parametric model of SARS-CoV-2 transmission in the United States.
    Drake JM; Handel A; Marty É; O'Dea EB; O'Sullivan T; Righi G; Tredennick AT
    PLoS Comput Biol; 2023 Nov; 19(11):e1011610. PubMed ID: 37939201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of metapopulation models of the transmission of SARS-CoV-2 in the United States.
    Vo M; Feng Z; Glasser JW; Clarke KEN; Jones JN
    J Math Biol; 2023 Jul; 87(2):24. PubMed ID: 37421486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mathematical Assessment of the Role of Human Behavior Changes on SARS-CoV-2 Transmission Dynamics in the United States.
    Pant B; Safdar S; Santillana M; Gumel AB
    Bull Math Biol; 2024 Jun; 86(8):92. PubMed ID: 38888744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic but infectious - The silent driver of pathogen transmission. A pragmatic review.
    Shaikh N; Swali P; Houben RMGJ
    Epidemics; 2023 Sep; 44():100704. PubMed ID: 37413887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric and Young Adult Household Transmission of the Initial Waves of SARS-CoV-2 in the United States: Administrative Claims Study.
    Chung MK; Hart B; Santillana M; Patel CJ
    J Med Internet Res; 2024 Jan; 26():e44249. PubMed ID: 37967280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of serological surveys of antibodies to SARS-CoV-2 in the United States to estimate parameters needed for transmission modeling and to evaluate and improve the accuracy of predictions.
    Glasser JW; Feng Z; Vo M; Jones JN; Clarke KEN
    J Theor Biol; 2023 Jan; 556():111296. PubMed ID: 36208669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review.
    Jefferson T; Spencer EA; Brassey J; Onakpoya IJ; Rosca EC; Plüddemann A; Evans DH; Conly JM; Heneghan CJ
    Clin Microbiol Infect; 2022 Feb; 28(2):178-189. PubMed ID: 34757116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of social distancing on early SARS-CoV-2 transmission in the United States.
    Sanchez JN; Reyes GA; Martínez-López B; Johnson CK
    Zoonoses Public Health; 2022 Sep; 69(6):746-756. PubMed ID: 35048530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring secondary SARS-CoV-2 transmission from asymptomatic cases using contact tracing data.
    Nakajo K; Nishiura H
    Theor Biol Med Model; 2021 Jul; 18(1):12. PubMed ID: 34271962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Panel Data Modeling and Surveillance of COVID-19 in Metropolitan Areas in the United States: Longitudinal Trend Analysis.
    Oehmke TB; Post LA; Moss CB; Issa TZ; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Feb; 23(2):e26081. PubMed ID: 33481757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing.
    Liu XX; Yang J; Fong S; Dey N; Millham RC; Fiaidhi J
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Hybrid Epidemic Model to Explore Stochasticity in COVID-19 Dynamics.
    Hwang KKL; Edholm CJ; Saucedo O; Allen LJS; Shakiba N
    Bull Math Biol; 2022 Jul; 84(9):91. PubMed ID: 35859080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection dynamics in Denmark, February through October 2020: Nature of the past epidemic and how it may develop in the future.
    Rasmussen S; Petersen MS; Høiby N
    PLoS One; 2021; 16(4):e0249733. PubMed ID: 33836034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the remote early detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Jun; 22(1):412. PubMed ID: 34158099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobility-Guided Estimation of COVID-19 Transmission Rates.
    Parker D; Pianykh O
    Am J Epidemiol; 2021 Jun; 190(6):1081-1087. PubMed ID: 33412586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Transmission Risk Among National Basketball Association Players, Staff, and Vendors Exposed to Individuals With Positive Test Results After COVID-19 Recovery During the 2020 Regular and Postseason.
    Mack CD; DiFiori J; Tai CG; Shiue KY; Grad YH; Anderson DJ; Ho DD; Sims L; LeMay C; Mancell J; Maragakis LL
    JAMA Intern Med; 2021 Jul; 181(7):960-966. PubMed ID: 33885715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic, Presymptomatic, and Asymptomatic Transmission of SARS-CoV-2 in a University Student Population, August-November 2020.
    Krieg SJ; Schnur JJ; Miranda ML; Pfrender ME; Chawla NV
    Public Health Rep; 2022; 137(5):1023-1030. PubMed ID: 35848117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the reliability of mobility metrics from aggregated mobile phone data as proxies for SARS-CoV-2 transmission in the USA: a population-based study.
    Kishore N; Taylor AR; Jacob PE; Vembar N; Cohen T; Buckee CO; Menzies NA
    Lancet Digit Health; 2022 Jan; 4(1):e27-e36. PubMed ID: 34740555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics of Viral Shedding for Outbreak Surveillance of Emerging Infectious Diseases: Modeling Approach to SARS-CoV-2 Alpha and Omicron Infection.
    Lin TY; Yen AM; Chen SL; Hsu CY; Lai CC; Luh DL; Yeh YP; Chen TH
    JMIR Public Health Surveill; 2024 Sep; 10():e54861. PubMed ID: 39298261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of five epidemiological models for transmission of SARS-CoV-2 in India.
    Purkayastha S; Bhattacharyya R; Bhaduri R; Kundu R; Gu X; Salvatore M; Ray D; Mishra S; Mukherjee B
    BMC Infect Dis; 2021 Jun; 21(1):533. PubMed ID: 34098885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.